| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Tau Ming Lie. Symptom Clusters of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Comparative Risks of Dementia: A Cohort Study of 8530 Older Persons. Journal of the American Medical Directors Association. vol 20. issue 8. 2020-11-11. PMID:30926409. |
neuropsychiatric symptoms (nps) have been recognized to increase the risk of dementia among individuals with mild cognitive impairment (mci). |
2020-11-11 |
2023-08-13 |
Not clear |
| Tau Ming Lie. Symptom Clusters of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Their Comparative Risks of Dementia: A Cohort Study of 8530 Older Persons. Journal of the American Medical Directors Association. vol 20. issue 8. 2020-11-11. PMID:30926409. |
this study sought to provide confirmatory evidence on the comparative risk of dementia across the various nps in mci. |
2020-11-11 |
2023-08-13 |
Not clear |
| José Ibiapina Siqueira-Neto, Octávio Marques Pontes-Neto, Francisco de Assis Carvalho do Vale, Júnia Vieira Dos Santos, Paulo Marcelo Gondim Sales, Júnia Vieira Dos Santos, Antônio Carlos Santo. Neuropsychiatric Symptoms (NPS) in patients with pure Vascular Dementia (VaD) and Mixed Dementia (MD) from a memory outpatient clinic in southeast Brazil. Dementia & neuropsychologia. vol 7. issue 3. 2020-10-01. PMID:29213849. |
neuropsychiatric symptoms (nps) in patients with pure vascular dementia (vad) and mixed dementia (md) from a memory outpatient clinic in southeast brazil. |
2020-10-01 |
2023-08-13 |
Not clear |
| Annibal Truzzi, Letice Valente, Eliasz Engelhardt, Jerson Lak. The association between caregiver distress and individual neuropsychiatric symptoms of dementia. Dementia & neuropsychologia. vol 7. issue 3. 2020-10-01. PMID:29213852. |
neuropsychiatric symptoms (nps) of dementia constitute one of the most related factors to caregiver burden and patients' early institutionalization. |
2020-10-01 |
2023-08-13 |
Not clear |
| Chan Tiel, Felipe Kenji Sudo, Ana Beatriz Calmo. Neuropsychiatric symptoms and executive function impairments in Alzheimer's disease and vascular dementia: The role of subcortical circuits. Dementia & neuropsychologia. vol 13. issue 3. 2020-10-01. PMID:31555401. |
neuropsychiatric symptoms (nps) in dementia are prevalent, under-recognized and little studied regarding their pathophysiological aspects. |
2020-10-01 |
2023-08-13 |
Not clear |
| Kok Pin Ng, Hui Jin Chiew, Pedro Rosa-Neto, Nagaendran Kandiah, Zahinoor Ismail, Serge Gauthie. Brain Metabolic Dysfunction in Early Neuropsychiatric Symptoms of Dementia. Frontiers in pharmacology. vol 10. 2020-10-01. PMID:31824321. |
neuropsychiatric symptoms (nps) including behavioral and psychiatric symptoms are common in the dementia stages of alzheimer's disease (ad) and are associated with poorer outcomes in cognition, functional states, quality of life, and accelerated progression to severe dementia or death. |
2020-10-01 |
2023-08-13 |
Not clear |
| Kok Pin Ng, Hui Jin Chiew, Pedro Rosa-Neto, Nagaendran Kandiah, Zahinoor Ismail, Serge Gauthie. Brain Metabolic Dysfunction in Early Neuropsychiatric Symptoms of Dementia. Frontiers in pharmacology. vol 10. 2020-10-01. PMID:31824321. |
nps are also increasingly observed in the mild cognitive impairment stage of ad and may predict incipient dementia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Kok Pin Ng, Hui Jin Chiew, Pedro Rosa-Neto, Nagaendran Kandiah, Zahinoor Ismail, Serge Gauthie. Brain Metabolic Dysfunction in Early Neuropsychiatric Symptoms of Dementia. Frontiers in pharmacology. vol 10. 2020-10-01. PMID:31824321. |
as such, there is an emerging conceptual framework, which support nps as early non-cognitive symptoms of dementia. |
2020-10-01 |
2023-08-13 |
Not clear |
| Javier Mar, Arantzazu Arrospide, Myriam Soto-Gordoa, Álvaro Iruin, Mikel Tainta, Andrea Gabilondo, Lore Mar-Barrutia, Montserrat Calvo, Maider Mateos, Oliver Ibarrond. Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization. Neuropsychiatric disease and treatment. vol 15. 2020-09-30. PMID:31413574. |
this study aimed to identify inequalities by gender and socioeconomic status in the management of nps in patients diagnosed with dementia. |
2020-09-30 |
2023-08-13 |
Not clear |
| Jodie Belinda Hillen, Natalie Soulsby, Chris Alderman, Gillian E Caughe. Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review. Therapeutic advances in drug safety. vol 10. 2020-09-29. PMID:31205674. |
neuropsychiatric symptoms (nps) in dementia impact profoundly on the quality of life of people living with dementia and their care givers. |
2020-09-29 |
2023-08-13 |
Not clear |
| Jodie Belinda Hillen, Natalie Soulsby, Chris Alderman, Gillian E Caughe. Safety and effectiveness of cannabinoids for the treatment of neuropsychiatric symptoms in dementia: a systematic review. Therapeutic advances in drug safety. vol 10. 2020-09-29. PMID:31205674. |
a literature review was undertaken to identify, describe and critically appraise studies investigating cannabinoid use in treating nps in dementia. |
2020-09-29 |
2023-08-13 |
Not clear |
| Michaela Defrancesco, Alex Hofe. Cannabinoid as Beneficial Replacement Therapy for Psychotropics to Treat Neuropsychiatric Symptoms in Severe Alzheimer's Dementia: A Clinical Case Report. Frontiers in psychiatry. vol 11. 2020-09-28. PMID:32477187. |
neuropsychiatric symptoms (nps) such as delusions, agitation, anxiety, and hallucinations are present in up to 95% of patients in all stages of dementia. |
2020-09-28 |
2023-08-13 |
Not clear |
| Yu-Yuan Huang, Kai-Xin Dou, Xiao-Ling Zhong, Xue-Ning Shen, Shi-Dong Chen, Hong-Qi Li, Ke-Liang Chen, Mei Cui, Qiang Dong, Lan Tan, Jin-Tai Y. Pharmacological treatment of neuropsychiatric symptoms of dementia: a network meta-analysis protocol. Annals of translational medicine. vol 8. issue 12. 2020-09-28. PMID:32647671. |
neuropsychiatric symptoms (nps) of dementia are a common issue in dementia patients which can lead to poor medical and functional outcomes. |
2020-09-28 |
2023-08-13 |
Not clear |
| Radoslaw Magierski, Tomasz Sobow, Emilia Schwertner, Dorota Relig. Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress. Frontiers in pharmacology. vol 11. 2020-09-28. PMID:32848775. |
the core symptoms of different dementia subtypes are the behavioral and psychological symptoms of dementia (bpsd) and its neuropsychiatric symptoms (nps). |
2020-09-28 |
2023-08-13 |
Not clear |
| Simon Dietlin, Maria Soto, Vera Kiyasova, Maria Pueyo, Adelaïde de Mauleon, Julien Delrieu, Pierre Jean Ousset, Bruno Vella. Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects. Journal of Alzheimer's disease : JAD. vol 70. issue 1. 2020-09-16. PMID:31127783. |
neuropsychiatric symptoms (nps) are prevalent in mild cognitive impairment (mci), but we do not know much about their role in progression to dementia. |
2020-09-16 |
2023-08-13 |
human |
| Vimal M Ag. When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 27. issue 10. 2020-09-02. PMID:31288974. |
the u.s. food and drug administration (u.s. fda) issued black box warnings against the use of antipsychotics in dementia in 2005 and 2008 due to the increased risk of morbidity and mortality, resulting in the reduction in antipsychotic use for treating dementia-related nps and spurring the quest for safer and more effective pharmacological options. |
2020-09-02 |
2023-08-13 |
Not clear |
| Byron Creese, Helen Brooker, Zahinoor Ismail, Keith A Wesnes, Adam Hampshire, Zunera Khan, Maria Megalogeni, Anne Corbett, Dag Aarsland, Clive Ballar. Mild Behavioral Impairment as a Marker of Cognitive Decline in Cognitively Normal Older Adults. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 27. issue 8. 2020-08-28. PMID:30902566. |
mild behavioral impairment (mbi) is a neurobehavioral syndrome characterized by later life emergent neuropsychiatric symptoms (nps) that represent an at-risk state for incident cognitive decline and dementia in people with mild cognitive impairment (mci). |
2020-08-28 |
2023-08-13 |
Not clear |
| Britt Appelhof, Christian Bakker, Marjolein E de Vugt, Jeannette C L van Duinen-van den IJssel, Sandra A Zwijsen, Martin Smalbrugge, Steven Teerenstra, Frans R J Verhey, Sytse U Zuidema, Raymond T C M Koopman. Effects of a Multidisciplinary Intervention on the Presence of Neuropsychiatric Symptoms and Psychotropic Drug Use in Nursing Home Residents WithYoung-Onset Dementia: Behavior and Evolution of Young-Onset Dementia Part 2 (BEYOND-II) Study. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. vol 27. issue 6. 2020-08-04. PMID:30799167. |
the effect of an intervention on neuropsychiatric symptoms (nps), particularly agitation and aggression, and psychotropic drug use (pdu) in institutionalized people with young-onset dementia (yod) was evaluated. |
2020-08-04 |
2023-08-13 |
Not clear |
| Britt Appelhof, Christian Bakker, Jeannette C L Van Duinen-van Den IJssel, Sandra A Zwijsen, Martin Smalbrugge, Frans R J Verhey, Marjolein E de Vugt, Sytse U Zuidema, Raymond T C M Koopman. Differences in neuropsychiatric symptoms between nursing home residents with young-onset dementia and late-onset dementia. Aging & mental health. vol 23. issue 5. 2020-07-20. PMID:29424552. |
the aims of the current study are (1) to explore the differences in neuropsychiatric symptoms (nps) between young-onset dementia (yod) and late-onset dementia (lod), and (2) to investigate whether the possible differences can be attributed to differences in dementia subtype, gender, psychotropic drug use (pdu), or dementia severity. |
2020-07-20 |
2023-08-13 |
Not clear |
| Jessica D Collins, Susie M D Henley, Aida Suárez-Gonzále. A systematic review of the prevalence of depression, anxiety, and apathy in frontotemporal dementia, atypical and young-onset Alzheimer's disease, and inherited dementia. International psychogeriatrics. 2020-07-20. PMID:32684177. |
in this study, we aimed to examine the current state of knowledge of the prevalence of these three nps in less prevalent dementias. |
2020-07-20 |
2023-08-13 |
Not clear |